Header Logo

Connection

HELEN HESLOP to Antineoplastic Combined Chemotherapy Protocols

Back to Details
This is a "connection" page, showing publications HELEN HESLOP has written about Antineoplastic Combined Chemotherapy Protocols.
HELEN HESLOP
Connection Strength
0.506
Antineoplastic Combined Chemotherapy Protocols
  1. Combining drugs and biologics to treat nasopharyngeal cancer. Mol Ther. 2014 Jan; 22(1):8-9.
    View in: PubMed
    Score: 0.243
  2. How I treat EBV lymphoproliferation. Blood. 2009 Nov 05; 114(19):4002-8.
    View in: PubMed
    Score: 0.045
  3. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007 Jul; 29(7):500-5.
    View in: PubMed
    Score: 0.039
  4. Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia. Cancer Treat Rev. 2003 Feb; 29(1):3-10.
    View in: PubMed
    Score: 0.028
  5. Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplant. 2022 04; 57(4):579-585.
    View in: PubMed
    Score: 0.027
  6. Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL. Cytotherapy. 2002; 4(3):253-8.
    View in: PubMed
    Score: 0.026
  7. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597.
    View in: PubMed
    Score: 0.025
  8. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. J Clin Oncol. 2020 11 10; 38(32):3794-3804.
    View in: PubMed
    Score: 0.024
  9. Blood and marrow transplant clinical trials network state of the Science Symposium 2014. Biol Blood Marrow Transplant. 2015 Feb; 21(2):202-24.
    View in: PubMed
    Score: 0.016
  10. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 02; 117(22):5835-49.
    View in: PubMed
    Score: 0.013
  11. A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease. Br J Cancer. 1989 Oct; 60(4):610-5.
    View in: PubMed
    Score: 0.011
  12. Sustained complete remission in Richter's syndrome. Cancer. 1987 Mar 01; 59(5):1036-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.